<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="symptoms with other endemic mosquito-borne pathogens in the region, including" exact="chikungunya" post="virus, dengue virus and malaria, ONNV infections are often"/>
 <result pre="joint pathology. Concordantly, in vivo CD4+ T cell depletion, or" exact="suppression" post="with fingolimod, an FDA-approved immunomodulating drug, abrogated CD4+ T"/>
 <result pre="endemic infectious diseases with more pronounced, overlapping symptoms, such as" exact="chikungunya" post="virus (CHIKV), dengue virus (DENV) or malaria. ONNV has"/>
 <result pre="revealed the presence of marked muscle degeneration and necrosis, mild" exact="synovitis" post="at the synovium, and tenosynovitis around the tendon capsule"/>
 <result pre="muscle degeneration and necrosis, mild synovitis at the synovium, and" exact="tenosynovitis" post="around the tendon capsule (Figures 1D,E). There were also"/>
 <result pre="characterized by marked muscle degeneration and necrosis, mild synovitis, and" exact="tenosynovitis" post="around the tendon capsule of the infected joint. However,"/>
 <result pre="of such FDA-approved drugs, together with their wide usage against" exact="multiple sclerosis" post="and rheumatoid arthritis, respectively, highlights the interesting possibility of"/>
 <result pre="drugs, together with their wide usage against multiple sclerosis and" exact="rheumatoid arthritis," post="respectively, highlights the interesting possibility of repositioning immune-modulating drugs"/>
 <result pre="Dis. (1999) 180:1436–43. 10.1086/31507310515801 7.KamYWPokKYEngKETanLKKaurSLeeWWLet al.. Sero-prevalence and cross-reactivity of" exact="chikungunya" post="virus specific anti-E2EP3 antibodies in arbovirus-infected patients. PLoS Negl"/>
 <result pre="56:166–72. 10.1016/0035-9203(62)90144-X14038061 9.LaBeaudADBandaTBrichardJMuchiriEMMungaiPLMutukuFMet al.. High rates of o'nyong nyong and" exact="chikungunya" post="virus transmission in coastal kenya. PLoS Negl Trop Dis."/>
 <result pre="12.KamY-WLeeWWLSimarmataDHarjantoSTengT-STolouHet al.. Longitudinal analysis of the human antibody response to" exact="chikungunya" post="virus infection: implications for serodiagnosis and vaccine development. J"/>
 <result pre="Inhibitors of alphavirus entry and replication identified with a stable" exact="chikungunya" post="replicon cell line and virus-based assays. PLoS ONE. (2011)"/>
 <result pre="assays. PLoS ONE. (2011) 6:e28923. 10.1371/journal.pone.002892322205980 14.ChanYTeoTUttATanJJAmrunSNAbu BakarFet al.. Mutating" exact="chikungunya" post="virus non-structural protein produces potent live-attenuated vaccine candidate. EMBO"/>
 <result pre="16.TeoTHLumFMClaserCLullaVLullaAMeritsAet al.. A pathogenic role for CD4+ T cells during" exact="chikungunya" post="virus infection in mice. J Immunol. (2013) 190:259–69. 10.4049/jimmunol.120217723209328"/>
 <result pre="arXiv. (2018) 3:180203426. 10.21105/joss.00861 20.HartimathSVDraghiciuOvan de WallSManuelliVDierckxRAJONijmanHWet al.Noninvasive monitoring of" exact="cancer" post="therapy induced activated t cells using [18f]fb-il-2 pet imaging."/>
 <result pre="[18f]fb-il-2 pet imaging. Oncoimmunology. (2017) 6:e124801410.1080/2162402X.2016.124801428197364 21.CarissimoGTorres-RuestaAChanY-HLeeBFongS-WChuaT-Ket al.. Viperin controls" exact="chikungunya" post="virus–specific pathogenic T cell IFNγ Th1 stimulation in mice."/>
 <result pre="Alliance. (2019) 2:e201900298. 10.26508/lsa.20190029830665948 22.TeoT-HHerZTanJJLLumFLeeWWLChanY-Het al.. Caribbean and la réunion" exact="chikungunya" post="virus isolates differ in their capacity to induce proinflammatory"/>
 <result pre="Virol. (2015) 89:7955–69. 10.1128/JVI.00909-1525995257 23.MorrisonTEOkoLMontgomerySAWhitmoreACLotsteinARGunnBMet al.. A mouse model of" exact="chikungunya" post="virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis,"/>
 <result pre="J Pathol. (2011) 178:32–40. 10.1016/j.ajpath.2010.11.01821224040 24.CarissimoGNgLFP. Understanding molecular pathogenesis with" exact="chikungunya" post="virus research tools. Curr Top Microbiol Immunol. (2019) 10.1007/82_2019_15830888547"/>
 <result pre="al.. Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls" exact="chikungunya" post="virus arthritis. Sci Transl Med. (2017) 9:eaah3438. 10.1126/scitranslmed.aah343828148840 27.RowellJFGriffinDE."/>
 <result pre="encephalomyelitis. J Neuroimmunol. (2002) 127:106–14. 10.1016/S0165-5728(02)00108-X12044981 28.TeoTChanYLeeWWLLumFAmrunSNHerZet al.Fingolimod treatment abrogates" exact="chikungunya" post="virus-induced arthralgia. Sci Transl Med. (2017) 1333:1–12. 10.1126/scitranslmed.aal1333 29.SeymourRLRossiSLBergrenNAPlanteKSWeaverSC."/>
</results>
